Literature DB >> 29767367

A Review of Transcriptome Analysis in Pulmonary Vascular Diseases.

Dustin R Fraidenburg1, Roberto F Machado2,3.   

Abstract

Transcriptome analysis is a powerful tool in the study of pulmonary vascular disease and pulmonary hypertension. Pulmonary hypertension is a disease process that consists of several unique pathologies sharing a common clinical definition, that of elevated pressure within the pulmonary circulation. As such, it has become increasingly important to identify both similarities and differences among the different classes of pulmonary hypertension. Transcriptome analysis has been an invaluable tool both in the basic science research on animal models as well as clinical research among the various different groups of pulmonary hypertension. This work has identified new potential candidate genes, implicated numerous biochemical and molecular pathways in diseased onset and progression, developed gene signatures to appropriately classify types of pulmonary hypertension and severity of illness, and identified novel gene mutations leading to hereditary forms of the disease.

Entities:  

Keywords:  Animal models; BMPR2; Hereditary pulmonary arterial hypertension; Lung disease; Pulmonary hypertension; Pulmonary vascular disease

Mesh:

Year:  2018        PMID: 29767367      PMCID: PMC6039103          DOI: 10.1007/978-1-4939-7834-2_13

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  76 in total

1.  miR-26a linked to pulmonary hypertension by global assessment of circulating extracellular microRNAs.

Authors:  Kenny Schlosser; R James White; Duncan J Stewart
Journal:  Am J Respir Crit Care Med       Date:  2013-12-15       Impact factor: 21.405

Review 2.  Endothelins.

Authors:  E R Levin
Journal:  N Engl J Med       Date:  1995-08-10       Impact factor: 91.245

3.  Gene expression profile in flow-associated pulmonary arterial hypertension with neointimal lesions.

Authors:  Mirjam E van Albada; Beatrijs Bartelds; Hans Wijnberg; Saffloer Mohaupt; Michael G Dickinson; Regien G Schoemaker; Krista Kooi; Frans Gerbens; Rolf M F Berger
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-12-18       Impact factor: 5.464

4.  Molecular signature of a right heart failure program in chronic severe pulmonary hypertension.

Authors:  Jennifer I Drake; Herman J Bogaard; Shiro Mizuno; Berrick Clifton; Bin Xie; Yuan Gao; Catherine I Dumur; Paul Fawcett; Norbert F Voelkel; Ramesh Natarajan
Journal:  Am J Respir Cell Mol Biol       Date:  2011-06-30       Impact factor: 6.914

5.  Pressure promotes DNA synthesis in rat cultured vascular smooth muscle cells.

Authors:  K Hishikawa; T Nakaki; T Marumo; M Hayashi; H Suzuki; R Kato; T Saruta
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

6.  Expression of endothelin-1 in the lungs of patients with pulmonary hypertension.

Authors:  A Giaid; M Yanagisawa; D Langleben; R P Michel; R Levy; H Shennib; S Kimura; T Masaki; W P Duguid; D J Stewart
Journal:  N Engl J Med       Date:  1993-06-17       Impact factor: 91.245

7.  Divergent selection for ascites incidence in chickens.

Authors:  H O Pavlidis; J M Balog; L K Stamps; J D Hughes; W E Huff; N B Anthony
Journal:  Poult Sci       Date:  2007-12       Impact factor: 3.352

8.  Gene expression profile of angiogenic factors in pulmonary arteries in COPD: relationship with vascular remodeling.

Authors:  Jéssica García-Lucio; Gemma Argemi; Olga Tura-Ceide; Marta Diez; Tanja Paul; Cristina Bonjoch; Nuria Coll-Bonfill; Isabel Blanco; Joan A Barberà; Melina M Musri; Victor I Peinado
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-01-22       Impact factor: 5.464

9.  Role for miR-204 in human pulmonary arterial hypertension.

Authors:  Audrey Courboulin; Roxane Paulin; Nellie J Giguère; Nehmé Saksouk; Tanya Perreault; Jolyane Meloche; Eric R Paquet; Sabrina Biardel; Steeve Provencher; Jacques Côté; Martin J Simard; Sébastien Bonnet
Journal:  J Exp Med       Date:  2011-02-14       Impact factor: 14.307

10.  Comparison of gene expression profiles and related pathways in chronic thromboembolic pulmonary hypertension.

Authors:  Song Gu; Pixiong Su; Jun Yan; Xitao Zhang; Xiangguang An; Jie Gao; Rui Xin; Yan Liu
Journal:  Int J Mol Med       Date:  2013-12-10       Impact factor: 4.101

View more
  3 in total

1.  Transcriptomic analysis of pulmonary artery smooth muscle cells identifies new potential therapeutic targets for idiopathic pulmonary arterial hypertension.

Authors:  Matthew W Gorr; Krishna Sriram; Abinaya Muthusamy; Paul A Insel
Journal:  Br J Pharmacol       Date:  2020-05-15       Impact factor: 8.739

Review 2.  NHLBI-CMREF Workshop Report on Pulmonary Vascular Disease Classification: JACC State-of-the-Art Review.

Authors:  William M Oldham; Anna R Hemnes; Micheala A Aldred; John Barnard; Evan L Brittain; Stephen Y Chan; Feixiong Cheng; Michael H Cho; Ankit A Desai; Joe G N Garcia; Mark W Geraci; Susan D Ghiassian; Kathryn T Hall; Evelyn M Horn; Mohit Jain; Rachel S Kelly; Jane A Leopold; Sara Lindstrom; Brian D Modena; William C Nichols; Christopher J Rhodes; Wei Sun; Andrew J Sweatt; Rebecca R Vanderpool; Martin R Wilkins; Beth Wilmot; Roham T Zamanian; Joshua P Fessel; Neil R Aggarwal; Joseph Loscalzo; Lei Xiao
Journal:  J Am Coll Cardiol       Date:  2021-04-27       Impact factor: 27.203

3.  Single-cell RNA sequencing profiling of mouse endothelial cells in response to pulmonary arterial hypertension.

Authors:  Julie Rodor; Shiau Haln Chen; Jessica P Scanlon; João P Monteiro; Axelle Caudrillier; Sweta Sweta; Katherine Ross Stewart; Alena Shmakova; Ross Dobie; Beth E P Henderson; Kevin Stewart; Patrick W F Hadoke; Mark Southwood; Stephen D Moore; Paul D Upton; Nick W Morrell; Ziwen Li; Stephen Y Chan; Adam Handen; Robert Lafyatis; Laura P M H de Rooij; Neil C Henderson; Peter Carmeliet; Ana Mishel Spiroski; Mairi Brittan; Andrew H Baker
Journal:  Cardiovasc Res       Date:  2022-08-24       Impact factor: 13.081

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.